In the context of metastasis, particularly in breast and prostate cancers, signals derived from tumors, such as TGF-β, IL-6, and extracellular vesicles (EVs), trigger epigenetic changes in cells residing in the bone [159,246]. Here, TGFB1 is linked to prostate carcinoma.